Emerging evidence shows that cancer cells can acquire super-enhancers in the vicinity of key oncogenes, such as MYC and TAL1, during the development of cancer (Hnisz et al., 2013; Herranz et al., 2014; Mansour et al., 2014). The gene discussed is TAL1; the disease is cancer.